NASDAQ:HOLX

Hologic Stock Forecast, Price & News

$77.15
-0.47 (-0.61 %)
(As of 09/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$76.55
$77.89
50-Day Range
$67.56
$80.74
52-Week Range
$59.71
$85.00
Volume1.28 million shs
Average Volume2.12 million shs
Market Capitalization$19.56 billion
P/E Ratio9.89
Dividend YieldN/A
Beta1.17
30 days | 90 days | 365 days | Advanced Chart
Receive HOLX News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.


Hologic logo

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment comprises products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.47 out of 5 stars

Medical Sector

126th out of 1,352 stocks

X-Ray Apparatus & Tubes Industry

1st out of 6 stocks

Analyst Opinion: 3.4Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Hologic (NASDAQ:HOLX) Frequently Asked Questions

Is Hologic a buy right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Hologic stock.
View analyst ratings for Hologic
or view top-rated stocks.

What stocks does MarketBeat like better than Hologic?

Wall Street analysts have given Hologic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Hologic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Hologic?

Hologic saw a decrease in short interest in the month of July. As of July 30th, there was short interest totaling 4,950,000 shares, a decrease of 19.5% from the July 15th total of 6,150,000 shares. Based on an average trading volume of 2,400,000 shares, the days-to-cover ratio is presently 2.1 days. Currently, 2.0% of the shares of the stock are sold short.
View Hologic's Short Interest
.

When is Hologic's next earnings date?

Hologic is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Hologic
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) posted its earnings results on Wednesday, July, 28th. The medical equipment provider reported $1.33 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.12 by $0.21. The medical equipment provider earned $1.17 billion during the quarter, compared to the consensus estimate of $1.03 billion. Hologic had a net margin of 35.98% and a trailing twelve-month return on equity of 67.74%. During the same quarter in the previous year, the company earned $0.75 EPS.
View Hologic's earnings history
.

How has Hologic's stock been impacted by COVID-19?

Hologic's stock was trading at $43.78 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HOLX stock has increased by 76.2% and is now trading at $77.15.
View which stocks have been most impacted by COVID-19
.

What guidance has Hologic issued on next quarter's earnings?

Hologic updated its fourth quarter 2021 earnings guidance on Wednesday, August, 4th. The company provided earnings per share (EPS) guidance of $0.920-$1.000 for the period, compared to the Thomson Reuters consensus estimate of $1.130. The company issued revenue guidance of $1 billion-$1.04 billion, compared to the consensus revenue estimate of $1.04 billion.

What price target have analysts set for HOLX?

12 brokerages have issued 12-month price objectives for Hologic's stock. Their forecasts range from $75.00 to $100.00. On average, they expect Hologic's stock price to reach $86.93 in the next year. This suggests a possible upside of 12.7% from the stock's current price.
View analysts' price targets for Hologic
or view top-rated stocks among Wall Street analysts.

Who are Hologic's key executives?

Hologic's management team includes the following people:
  • Stephen P. MacMillan, Chairman, President & Chief Executive Officer
  • Karleen Marie Oberton, Chief Financial Officer
  • Jay A. Stein, Chairman-Emeritus, Chief Technology Officer & SVP
  • Patricia K. Dolan, Secretary & Vice President
  • Jan Verstreken, Group President-International

What is Steve MacMillan's approval rating as Hologic's CEO?

283 employees have rated Hologic CEO Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among Hologic's employees.

Who are some of Hologic's key competitors?

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), The Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by a variety of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (14.80%), Vanguard Group Inc. (11.03%), BlackRock Inc. (8.49%), FMR LLC (5.95%), State Street Corp (4.34%) and Geode Capital Management LLC (2.12%). Company insiders that own Hologic stock include Benjamin Jordan Cohn, Christiana Stamoulis, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Peter J Valenti III, Sally Crawford, Sean S Daugherty and Stephen P Macmillan.
View institutional ownership trends for Hologic
.

Which institutional investors are selling Hologic stock?

HOLX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Price T Rowe Associates Inc. MD, Marshall Wace North America L.P., Teacher Retirement System of Texas, Nuveen Asset Management LLC, Goldman Sachs Group Inc., Sumitomo Mitsui Trust Holdings Inc., and Capula Management Ltd. Company insiders that have sold Hologic company stock in the last year include Benjamin Jordan Cohn, Kevin R Thornal, and Sean S Daugherty.
View insider buying and selling activity for Hologic
or view top insider-selling stocks.

Which institutional investors are buying Hologic stock?

HOLX stock was bought by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, Massachusetts Financial Services Co. MA, Parnassus Investments CA, Amundi, Vaughan Nelson Investment Management L.P., Armistice Capital LLC, AQR Capital Management LLC, and UBS Asset Management Americas Inc..
View insider buying and selling activity for Hologic
or or view top insider-buying stocks.

How do I buy shares of Hologic?

Shares of HOLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $77.15.

How much money does Hologic make?

Hologic has a market capitalization of $19.56 billion and generates $3.78 billion in revenue each year. The medical equipment provider earns $1.12 billion in net income (profit) each year or $3.98 on an earnings per share basis.

How many employees does Hologic have?

Hologic employs 5,814 workers across the globe.

Does Hologic have any subsidiaries?

The following companies are subsidiares of Hologic: Focal Therapeutics.

When was Hologic founded?

Hologic was founded in 1985.

What is Hologic's official website?

The official website for Hologic is www.hologic.com.

Where are Hologic's headquarters?

Hologic is headquartered at 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752.

How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at (508) 263-2900 or via email at [email protected]


This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.